Design Therapeutics appoints Chris Storgard as CMO

Design Therapeutics (DSGN) announced the appointment of Chris Storgard, M.D., as Chief Medical Officer. Most recently, Dr. Storgard served as CMO at ADARx Pharmaceuticals, where he transitioned the organization from research to development-stage operations, overseeing the advancement of multiple clinical programs, including preparations for the company’s first global Phase 3 program.